Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cost-effectiveness of screening for asymptomatic carotid stenosis

Published byFanny Hoch Modified over 5 years ago

Similar presentations

Presentation on theme: "Cost-effectiveness of screening for asymptomatic carotid stenosis"— Presentation transcript:

1 Cost-effectiveness of screening for asymptomatic carotid stenosis
Dongping Yin, PhD, Jeffrey P. Carpenter, MD  Journal of Vascular Surgery  Volume 27, Issue 2, Pages (February 1998) DOI: /S (98) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

2 Fig. 1 Decision tree of events in month after decision to screen. Square nodes represent decisions, and circular nodes are chance nodes. Model accounts for complications of arteriography and fate of patients who had false-positive ultrasound scans. Patients enter Markov process after decision to screen (Fig. 2). Angio, carotid arteriography; Comp, complications; Dz, patient has 60% to 99% asymptomatic carotid stenosis; Surg, carotid endarterectomy. Journal of Vascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

3 Fig. 2 A, Markov model for fate of patients after screening. Well, Asym, Sym, AsymSurg, SymSurg, MinStk, MajStk, and Death are Markov states (Table I). Patients who are aging may move from one of eight Markov states to another (i.e., from Well to Asym). B, Markov model for monthly transition for patients who develop asymptomatic stenosis after screening has been completed. Patients may have stroke, remain asymptomatic, or develop symptoms. Those developing symptoms (i.e., transient ischemic attack) are assumed to undergo ultrasound testing and then arteriographic verification and endarterectomy in patients with confirmed 60% to 99% stenosis. Square nodes represent decisions and circular nodes are chance nodes. Angio, carotid arteriography; Comp, complications; Dz, 60% to 99% stenosis; Surg, Carotid endarterectomy. Journal of Vascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

4 Fig. 3 Solid line shows prevalence of disease in screening population and cost-effectiveness of screening. Screening was cost-effective if prevalence of asymptomatic carotid stenosis was more than 4.5%. Dashed line shows surgical efficacy for patients who were asymptomatic and cost-effectiveness of screening. Screening was cost-effective if surgical efficacy was more than 37%. Surgical efficacy, (rate of stroke in medical patients - rate of stroke in surgical patients)/(rate of stroke in medical patients); CE-Ratio, Cost/QALY = (cost of screening - cost of not screening)/(QALY of screening - QALY of not screening). Journal of Vascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

5 Fig. 4 Surgical complications and cost-effectiveness of screening. Screening was cost-effective if surgical complication rate was less than 160% of that in ACAS and NASCET. Surgical complications, rate of surgical complications compared with rates of complications in ACAS (for asymptomatic patients) and NASCET (for symptomatic patients); CE-Ratio, Cost/QALY = (cost of screening - cost of not screening )/(QALY of screening - QALY of not screening). Journal of Vascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

6 Fig. 5 Sensitivity and specificity of ultrasound and cost-effectiveness of screening. Cost-effectiveness of screening was independent of sensitivity of ultrasound (dashed line). Screening was cost-effective if specificity of ultrasound was more than 91% (solid line). CE-Ratio, Cost/QALY = (cost of screening - cost of not screening )/(QALY of screening - QALY of not screening). Journal of Vascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

7 Fig. 6 Annual rate of strokes in patients with 60% to 99% asymptomatic stenosis and cost-effectiveness of screening. Screening was cost-effective if stroke rate of patients who were medically managed and asymptomatic was more than 3.3%. CE-Ratio, Cost/QALY = (cost of screening - cost of not screening)/(QALY of screening - QALY of not screening). Journal of Vascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

8 Fig. 7 Cost of ultrasound and cost-effectiveness of screening. Screening was cost-effective if cost of ultrasound was less than $300. CE-Ratio, Cost/QALY = (cost of screening - cost of not screening)/(QALY of screening - QALY of not screening). Journal of Vascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

9 Fig. 8 Rate of carotid arteriography-related complications and cost-effectiveness of screening. Screening was cost-effective if rate of arteriographic complications was less than 1.4%. CE-Ratio, Cost/QALY = (cost of screening - cost of not screening)/(QALY of screening - QALY of not screening). Journal of Vascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Download ppt "Cost-effectiveness of screening for asymptomatic carotid stenosis"

Similar presentations

Timing of carotid endarterectomy after acute stroke Joseph J. Plotrowski, MD, Victor M. Bernhard, MD, Jeffrey R. Rubin, MD, Kenneth E. McIntyre, MD, James.

Timing of carotid endarterectomy after acute stroke Joseph J. Plotrowski, MD, Victor M. Bernhard, MD, Jeffrey R. Rubin, MD, Kenneth E. McIntyre, MD, James.
The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.

The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.
A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,
Jeffrey R. Rubin, M. D. , Jerry Goldstone, M. D. , Kenneth E

Jeffrey R. Rubin, M. D. , Jerry Goldstone, M. D. , Kenneth E
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Asymptomatic high-grade internal carotid artery stenosis: Is stratification according to risk factors or duplex spectral analysis possible?  Gregory L.

Asymptomatic high-grade internal carotid artery stenosis: Is stratification according to risk factors or duplex spectral analysis possible?  Gregory L.
Ultrasound measurement of the luminal diameter of the abdominal aorta and iliac arteries in patients without vascular disease  Ole Martin Pedersen, MD,

Ultrasound measurement of the luminal diameter of the abdominal aorta and iliac arteries in patients without vascular disease  Ole Martin Pedersen, MD,
Preoperative statin and diuretic use influence the presentation of patients undergoing carotid endarterectomy: Results of a large single-institution case-control.

Preoperative statin and diuretic use influence the presentation of patients undergoing carotid endarterectomy: Results of a large single-institution case-control.
Value of single photon emission computerized imaging in the treatment of patients undergoing carotid endarterectomy  Roy L. Tawes, MD, Robert Lull, MD 

Value of single photon emission computerized imaging in the treatment of patients undergoing carotid endarterectomy  Roy L. Tawes, MD, Robert Lull, MD 
Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis.

Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis.
Can the NASCET technique for measuring carotid stenosis be reliably applied outside the trial?  Paul J. Gagne, MD, Jean Matchett, MD, David MacFarland,

Can the NASCET technique for measuring carotid stenosis be reliably applied outside the trial?  Paul J. Gagne, MD, Jean Matchett, MD, David MacFarland,
M. Ashraf Mansour, MD, Fred N. Littooy, MD, William C

M. Ashraf Mansour, MD, Fred N. Littooy, MD, William C
Mycotic axillary artery aneurysm

Mycotic axillary artery aneurysm
Surgical management of infected abdominal aortic grafts: Review of a 25-year experience  Patrick J. O'Hara, M.D., Norman R. Hertzer, M.D., Edwin G. Beven,

Surgical management of infected abdominal aortic grafts: Review of a 25-year experience  Patrick J. O'Hara, M.D., Norman R. Hertzer, M.D., Edwin G. Beven,
Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy.

Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy.
Mark D. Morasch, MD, Michele A

Mark D. Morasch, MD, Michele A
Carotid endarterectomy in patients less than 50 years old

Carotid endarterectomy in patients less than 50 years old
Malcolm O. Perry, MD, Richard Kempczinski, MD 

Malcolm O. Perry, MD, Richard Kempczinski, MD 
Jeffrey R. Rubin, M. D. , Jerry Goldstone, M. D. , Kenneth E

Jeffrey R. Rubin, M. D. , Jerry Goldstone, M. D. , Kenneth E
David Rosenthal, MD, Edgar Borrero, MD, Michael D. Clark, MD, Pano A

David Rosenthal, MD, Edgar Borrero, MD, Michael D. Clark, MD, Pano A

Similar presentations

Ads by Google